Granahan Investment Management, LLC Standard Biotools Inc. Transaction History

Granahan Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$4.34 - $11.43 $2.05 Million - $5.41 Million	-472,970 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.85 - $5.29 $499,028 - $1.43 Million	-269,745 Reduced 36.32%	472,970 $1.9 Million
Q1 2020 May 12, 2020	BUY	$1.24 - $4.35 $70,644 - $247,823	56,971 Added 8.31%	742,715 $1.89 Million
Q4 2019 Feb 14, 2020	BUY	$2.3 - $5.12 $204,389 - $454,988	88,865 Added 14.89%	685,744 $2.39 Million
Q3 2019 Nov 15, 2019	SELL	$4.63 - $12.15 $641,296 - $1.68 Million	-138,509 Reduced 18.83%	596,879 $2.76 Million
Q2 2019 Aug 14, 2019	SELL	$11.49 - $14.17 $525,437 - $647,994	-45,730 Reduced 5.85%	735,388 $9.06 Million
Q1 2019 May 14, 2019	BUY	$8.47 - $14.36 $1.86 Million - $3.15 Million	219,426 Added 39.07%	781,118 $10.4 Million
Q4 2018 Feb 13, 2019	BUY	$7.18 - $8.83 $4.03 Million - $4.96 Million	561,692 New	561,692 $4.84 Million

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $126M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.